Report of the Australian Rotavirus Surveillance Program 2003-2004

Carl Kirkwood1, Nada Bogdanovic-Sakran, Ruth Bishop

  • 1National Rotavirus Reference Centre, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria.

Insights

Rotavirus surveillance in Australian children from 2003-2004 found G1 strains re-emerged as the most common cause of gastroenteritis hospitalizations. Findings impact rotavirus vaccine development strategies.

Area of Science:

  • Virology
  • Public Health
  • Epidemiology

Background:

  • Rotavirus is a leading cause of severe gastroenteritis in young children globally.
  • Continuous surveillance is crucial for understanding circulating strains and informing public health interventions.
  • The National Rotavirus Reference Centre has monitored rotavirus epidemiology in Australia since 1999.

Purpose of the Study:

  • To identify the predominant rotavirus serotypes causing hospitalizations in children with acute gastroenteritis in Australia.
  • To analyze geographic variations in rotavirus serotype prevalence.
  • To inform rotavirus vaccine development and public health strategies.

Main Methods:

  • Analysis of 688 faecal samples from hospitalized children with acute gastroenteritis.
  • Utilized monoclonal antibody immunoassays for serotyping.
  • Employed reverse transcription-polymerase chain reaction (RT-PCR) and polyacrylamide gel electrophoresis (PAGE) for strain characterization.

Main Results:

  • Serotype G1 re-emerged as the dominant strain, accounting for 40% of cases.
  • Other significant serotypes included G3 (25.7%), G2 (17.1%), and G9 (11.7%).
  • Substantial geographic variations in serotype distribution were observed across Australia.

Conclusions:

  • Rotavirus G1 is the primary serotype responsible for pediatric gastroenteritis hospitalizations in Australia.
  • Geographic disparities in serotype prevalence necessitate tailored public health approaches.
  • These epidemiological findings are critical for guiding the development of effective rotavirus vaccines targeting prevalent serotypes.